18 insiders reported 124 Form 4 transactions for Oruka Therapeutics, Inc. (ORKA) over the past 18 months (most recent 2026-07-01). Recent activity: Harwin Peter Evan (Director) Buy 3.6M shares, Sandler Laura Lee (Chief Operating Officer) Sell 500 shares, Fairmount Funds Management LLC (Director) Buy 3.6M shares, Kiselak Tomas (Director) Buy 3.6M shares, Fairmount Healthcare Co-Invest III L.P. (Director) Buy 3.6M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Harwin Peter Evan | Director | Buy | 3.6M | $0 |
| 2026-07-01 | Sandler Laura Lee | Chief Operating Officer | Sell | 500 | $47,736 |
| 2026-07-01 | Fairmount Funds Management LLC | Director | Buy | 3.6M | $0 |
| 2026-07-01 | Kiselak Tomas | Director | Buy | 3.6M | $0 |
| 2026-07-01 | Fairmount Healthcare Co-Invest III L.P. | Director | Buy | 3.6M | $0 |
| 2026-07-01 | Sandler Laura Lee | Chief Operating Officer | Buy | 5,000 | $39,000 |
| 2026-07-01 | Harwin Peter Evan | Director | Sell | 3.6M | $300.0M |
| 2026-07-01 | Fairmount Healthcare Fund II L.P. | Director | Buy | 3.6M | $0 |
| 2026-07-01 | Fairmount Funds Management LLC | Director | Sell | 3.6M | $300.0M |
| 2026-07-01 | Kiselak Tomas | Director | Sell | 3.6M | $300.0M |
| 2026-07-01 | Fairmount Healthcare Co-Invest III L.P. | Director | Sell | 3.6M | $300.0M |
| 2026-07-01 | Sandler Laura Lee | Chief Operating Officer | Sell | 2,237 | $209,933 |
| 2026-07-01 | Sandler Laura Lee | Chief Operating Officer | Sell | 2,263 | $214,410 |
| 2026-07-01 | Fairmount Healthcare Fund II L.P. | Director | Sell | 3.6M | $300.0M |
| 2026-06-22 | Agarwal Arjun | Senior Vice President, Finance | Sell | 888 | $71,049 |
| 2026-06-22 | Agarwal Arjun | Senior Vice President, Finance | Sell | 699 | $57,419 |
| 2026-06-12 | Dambkowski Carl | Director | Sell | 22,417 | $1.6M |
| 2026-06-12 | Dambkowski Carl | Director | Sell | 12,583 | $882,182 |
| 2026-05-22 | Dambkowski Carl | Director | Buy | 38,689 | $264,633 |
| 2026-05-22 | Dambkowski Carl | Director | Buy | 11,667 | $137,321 |
| 2026-05-22 | Dambkowski Carl | Director | Sell | 38,318 | $2.2M |
| 2026-05-22 | Dambkowski Carl | Director | Sell | 53,447 | $3.2M |
| 2026-05-22 | Dambkowski Carl | Director | Sell | 13,235 | $793,662 |
| 2026-05-22 | Dambkowski Carl | Director | Buy | 11,904 | $92,851 |
| 2026-05-18 | Agarwal Arjun | Senior Vice President, Finance | Buy | 2,000 | $25,000 |
Source: SEC Form 4 filings · as of 2026-07-01